AR077739A1 - Tapones lagrimales - Google Patents
Tapones lagrimalesInfo
- Publication number
- AR077739A1 AR077739A1 ARP100101012A ARP100101012A AR077739A1 AR 077739 A1 AR077739 A1 AR 077739A1 AR P100101012 A ARP100101012 A AR P100101012A AR P100101012 A ARP100101012 A AR P100101012A AR 077739 A1 AR077739 A1 AR 077739A1
- Authority
- AR
- Argentina
- Prior art keywords
- plugs
- tear
- tear plugs
- anchor
- elongated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00772—Apparatus for restoration of tear ducts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Plastic & Reconstructive Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Prostheses (AREA)
Abstract
Se describen tapones lagrimales adecuados para suministrar agentes terapéuticos; los tapones tienen un cuerpo, una porcion en la cual se carga el agente terapéutico, un bobinado alrededor del cuerpo, y una alargada o de anclaje en un extremo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16541709P | 2009-03-31 | 2009-03-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR077739A1 true AR077739A1 (es) | 2011-09-21 |
Family
ID=42320849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP100101012A AR077739A1 (es) | 2009-03-31 | 2010-03-29 | Tapones lagrimales |
Country Status (14)
Country | Link |
---|---|
US (1) | US20100256578A1 (es) |
EP (1) | EP2413853A1 (es) |
JP (1) | JP2012521858A (es) |
KR (1) | KR20120013346A (es) |
CN (1) | CN102448412A (es) |
AR (1) | AR077739A1 (es) |
AU (1) | AU2010234879A1 (es) |
BR (1) | BRPI1014062A2 (es) |
CA (1) | CA2758054A1 (es) |
RU (1) | RU2011143792A (es) |
SG (2) | SG174972A1 (es) |
TW (1) | TWI495459B (es) |
UY (1) | UY32538A (es) |
WO (1) | WO2010117722A1 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7431710B2 (en) | 2002-04-08 | 2008-10-07 | Glaukos Corporation | Ocular implants with anchors and methods thereof |
US9421127B2 (en) * | 2009-03-31 | 2016-08-23 | Johnson & Johnson Vision Care, Inc. | Punctal plugs |
US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
US9259351B2 (en) | 2010-03-29 | 2016-02-16 | Johnson & Johnson Vision Care, Inc. | Punctal plugs |
US9259352B2 (en) * | 2010-03-29 | 2016-02-16 | Johnson & Johnson Vision Care, Inc. | Punctal plugs |
US20110301555A1 (en) * | 2010-06-03 | 2011-12-08 | Gonzalez-Zugasti Javier P | Porous matrix drug core for lacrimal insert device |
US10245178B1 (en) | 2011-06-07 | 2019-04-02 | Glaukos Corporation | Anterior chamber drug-eluting ocular implant |
JP6655610B2 (ja) | 2014-05-29 | 2020-02-26 | グローコス コーポレーション | 制御された薬物送達機能を備えるインプラント及びそれを使用する方法 |
CN104398328A (zh) * | 2014-09-30 | 2015-03-11 | 浦易(上海)生物技术有限公司 | 一种可完全降解的载药的鼻泪管支架及其植入系统 |
WO2017040853A1 (en) | 2015-09-02 | 2017-03-09 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
WO2017053885A1 (en) | 2015-09-25 | 2017-03-30 | Glaukos Corporation | Punctal implants with controlled drug delivery features and methods of using same |
CN105879126A (zh) * | 2016-03-24 | 2016-08-24 | 杭州亚慧生物科技有限公司 | 一种超润滑血清白蛋白泪点塞及其制备方法 |
JP7003110B2 (ja) | 2016-04-20 | 2022-01-20 | ドーズ メディカル コーポレーション | 生体吸収性眼球薬物送達デバイス |
CN106667656A (zh) * | 2016-06-30 | 2017-05-17 | 广州聚明生物科技有限公司 | 生物可降解泪道栓及其制备方法和应用 |
CN106491270B (zh) * | 2016-12-23 | 2018-08-14 | 中国医科大学附属第一医院 | 一种泪点扩张装置 |
CN110711075A (zh) * | 2018-07-11 | 2020-01-21 | 吴坚 | 一种泪小管栓塞 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3906551A (en) * | 1974-02-08 | 1975-09-23 | Klaas Otter | Artificial intra-ocular lens system |
US3949750A (en) * | 1974-10-07 | 1976-04-13 | Freeman Jerre M | Punctum plug and method for treating keratoconjunctivitis sicca (dry eye) and other ophthalmic aliments using same |
US4915684A (en) * | 1988-06-21 | 1990-04-10 | Mackeen Donald L | Method and apparatus for modulating the flow of lacrimal fluid through a punctum and associated canaliculus |
US4959048A (en) * | 1989-01-17 | 1990-09-25 | Helix Medical, Inc. | Lacrimal duct occluder |
US5334137A (en) * | 1992-02-21 | 1994-08-02 | Eagle Vision, Inc. | Lacrimal fluid control device |
US5423777A (en) * | 1993-10-27 | 1995-06-13 | Tajiri; Akira | Punctum plug |
US6149684A (en) * | 1995-06-07 | 2000-11-21 | Herrick; Robert S. | Punctum plug having a thin elongated lip and a distal starting tip and method of using |
EP0944371A1 (fr) * | 1997-02-04 | 1999-09-29 | Alain Fouere | Tampon meatique vissable pour canal lacrymal |
US6082362A (en) * | 1997-03-27 | 2000-07-04 | Eagle Vision, Inc. | Punctum plug |
US6041785A (en) * | 1997-03-27 | 2000-03-28 | Eaglevision, Inc. | Punctum plug |
US5962548A (en) * | 1998-03-02 | 1999-10-05 | Johnson & Johnson Vision Products, Inc. | Silicone hydrogel polymers |
US6822016B2 (en) * | 2001-09-10 | 2004-11-23 | Johnson & Johnson Vision Care, Inc. | Biomedical devices containing internal wetting agents |
US6367929B1 (en) * | 1998-03-02 | 2002-04-09 | Johnson & Johnson Vision Care, Inc. | Hydrogel with internal wetting agent |
US6196993B1 (en) * | 1998-04-20 | 2001-03-06 | Eyelab Group, Llc | Ophthalmic insert and method for sustained release of medication to the eye |
US6099852A (en) * | 1998-09-23 | 2000-08-08 | Johnson & Johnson Vision Products, Inc. | Wettable silicone-based lenses |
US6629533B1 (en) * | 2000-06-30 | 2003-10-07 | Eagle Vision, Inc. | Punctum plug with at least one anchoring arm |
FR2829019B3 (fr) * | 2001-08-31 | 2003-10-31 | Alain Fouere | Bouchons lacrymaux et methodes de mise en place de ces dispositifs |
US7204253B2 (en) * | 2003-05-22 | 2007-04-17 | Clarity Corporation | Punctum plug |
US20050232972A1 (en) * | 2004-04-15 | 2005-10-20 | Steven Odrich | Drug delivery via punctal plug |
EP3470108A1 (en) * | 2004-07-02 | 2019-04-17 | Mati Therapeutics Inc. | Treatment medium delivery device for delivery of treatment media to the eye |
US20060020253A1 (en) * | 2004-07-26 | 2006-01-26 | Prescott Anthony D | Implantable device having reservoir with controlled release of medication and method of manufacturing the same |
US20060276738A1 (en) * | 2005-06-06 | 2006-12-07 | Becker Bruce B | Lacrimal drainage bypass device and method |
US8088161B2 (en) * | 2005-07-28 | 2012-01-03 | Visioncare Ophthalmic Technologies Inc. | Compressed haptics |
DK2010096T3 (en) * | 2006-03-31 | 2017-10-02 | Mati Therapeutics Inc | NASOLACRIMAL DRAINAGE SYSTEM IMPLANTS FOR PHARMACEUTICAL THERAPY |
SG138567A1 (en) * | 2006-06-21 | 2008-01-28 | Johnson & Johnson Vision Care | Punctal plugs for the delivery of active agents |
US20080045911A1 (en) * | 2006-06-21 | 2008-02-21 | Borgia Maureen J | Punctal plugs for the delivery of active agents |
US9474645B2 (en) * | 2006-06-21 | 2016-10-25 | Johnson & Johnson Vision Care, Inc. | Punctal plugs for the delivery of active agents |
RU2009128703A (ru) * | 2006-12-26 | 2011-02-10 | Клт Плаг Диливери, Инк. (Us) | Имплантаты, доставляющие лекарства, для уменьшения оптических дефектов |
UY30883A1 (es) * | 2007-01-31 | 2008-05-31 | Alcon Res | Tapones punctales y metodos de liberacion de agentes terapeuticos |
NZ598483A (en) * | 2007-09-07 | 2013-08-30 | Quadra Logic Tech Inc | Drug cores for sustained release of therapeutic agents |
TWI542338B (zh) * | 2008-05-07 | 2016-07-21 | 壯生和壯生視覺關懷公司 | 用於活性劑之控制釋放的眼用裝置 |
MX2011007804A (es) * | 2009-01-23 | 2011-12-06 | Quadra Logic Tech Inc | Suministro de liberación sostenida de uno o más agentes. |
US8911495B2 (en) * | 2009-03-16 | 2014-12-16 | Endoshape, Inc. | Reliably retained shape memory ophthalmological implants |
-
2010
- 2010-03-26 TW TW099109003A patent/TWI495459B/zh not_active IP Right Cessation
- 2010-03-29 CA CA2758054A patent/CA2758054A1/en not_active Abandoned
- 2010-03-29 AU AU2010234879A patent/AU2010234879A1/en not_active Abandoned
- 2010-03-29 US US12/749,085 patent/US20100256578A1/en not_active Abandoned
- 2010-03-29 BR BRPI1014062A patent/BRPI1014062A2/pt not_active IP Right Cessation
- 2010-03-29 JP JP2012503554A patent/JP2012521858A/ja active Pending
- 2010-03-29 RU RU2011143792/14A patent/RU2011143792A/ru not_active Application Discontinuation
- 2010-03-29 KR KR1020117025338A patent/KR20120013346A/ko not_active Application Discontinuation
- 2010-03-29 CN CN2010800237996A patent/CN102448412A/zh active Pending
- 2010-03-29 WO PCT/US2010/029048 patent/WO2010117722A1/en active Application Filing
- 2010-03-29 EP EP10722840A patent/EP2413853A1/en not_active Withdrawn
- 2010-03-29 SG SG2011070877A patent/SG174972A1/en unknown
- 2010-03-29 AR ARP100101012A patent/AR077739A1/es unknown
- 2010-03-29 SG SG10201401086VA patent/SG10201401086VA/en unknown
- 2010-04-05 UY UY0001032538A patent/UY32538A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
UY32538A (es) | 2010-09-30 |
SG10201401086VA (en) | 2014-10-30 |
WO2010117722A1 (en) | 2010-10-14 |
BRPI1014062A2 (pt) | 2016-04-12 |
US20100256578A1 (en) | 2010-10-07 |
SG174972A1 (en) | 2011-11-28 |
TW201039805A (en) | 2010-11-16 |
JP2012521858A (ja) | 2012-09-20 |
KR20120013346A (ko) | 2012-02-14 |
CN102448412A (zh) | 2012-05-09 |
CA2758054A1 (en) | 2010-10-14 |
RU2011143792A (ru) | 2013-05-10 |
TWI495459B (zh) | 2015-08-11 |
EP2413853A1 (en) | 2012-02-08 |
AU2010234879A1 (en) | 2011-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR077739A1 (es) | Tapones lagrimales | |
UY32537A (es) | Tapones lagrimales | |
CR20120345A (es) | Derivados de 3-hidroxi-5-arilisotiazol novedosos | |
CL2016002372A1 (es) | Cenicriviroc para el tratamiento de la fibrosis. | |
CL2011001811A1 (es) | Un metodo para tratar un paciente que ha sufrido un infarto agudo al miocardio que comprende el uso de un agente antifibrotico. | |
CL2015000345A1 (es) | Uso de una combinación para el melanoma que comprende la administración de cobimetinib y vemurafenib. | |
CL2015003135A1 (es) | Derivados de 2,2-difluoropropanamida y metil bardoxolona, formas polimorficas y métodos de uso. | |
BRPI0822885A2 (pt) | Implemento para cuidado oral, método para administrar um agente ativo, e, kit para cuidado oral | |
CO6640295A2 (es) | Conjunto de anclaje que incluye un anclaje expansible | |
CL2011000916A1 (es) | Uso de una combinacion de un inhibidor de proteasoma epoxicetona peptidica o una sal farmaceutica aceptable del mismo, y uno o mas de otros agentes terapeuticos para tratar el cancer. | |
DOP2012000245A (es) | Composiciones sólidas | |
CL2013000718A1 (es) | Un complejo de inclusion que comprende a) una ciclodextrina, b) fulvestrant y c) un portador; su metodo de preparacion; formulacion y forma de dosificacion que comprende al complejo; preparacion que comprende al complejo o a la formulación; y su uso en el tratamiento del cancer y lupus eritematoso sistemico, entre otras enfermedades. | |
IL254813B (en) | Sustained-release injectable formulations containing isoxazoline active agent and methods and uses thereof | |
CL2013001136A1 (es) | Un agente inhibitorio de la fosfodiesterasa 7 (pde7) para ser usado en el tratamiento o la reduccion de la posibilidad de una adiccion; y composicion farmaceutica, forma de dosificacion unitaria y kit farmaceutico que incluyen al inhibidor de fosfodiesterasa 7 (pde7) y un agente terapeutico adicional. | |
AR105205A1 (es) | Sustrato adhesivo desechable adaptado para ser dispuesto sobre un dispositivo médico | |
WO2016149501A3 (en) | Modified therapeutic agents and compositions thereof | |
CL2014001002A1 (es) | Perno de anclaje en roca que incluye un cuerpo cilindrico alargado que tiene, un primer extremo distal y un segundo extremo proximal opuesto, una porcion roscada en el segundo extremo, un primer anclaje situado en o al menos parcialmente situado en una primera porcion de extremo del cuerpo, un segundo anclaje, una primera porcion de vastago entre el primer y el segundo anclaje. | |
BRPI0910760A2 (pt) | método para remineralizar tecido, agente remineralizador, e, kit | |
CL2017001964A1 (es) | Encapsulado de agentes activos de alta potencia. | |
PE20161158A1 (es) | Aparato y metodo de apoyo en tierra | |
CL2013002905A1 (es) | Composición farmacéutica que comprende fimasartan, una sal, solvato o hidrato del mismo y amlodipina, un isómero, sal, solvato o hidrato del mismo; uso en el tratamiento de hipertensión y enfermedades cardiovasculares. | |
AR056500A1 (es) | Metodo para preparar una composicion medica | |
MX2015011784A (es) | Dispositivo de terapia para periimplantitis. | |
CL2014001468A1 (es) | Un componente de cable que comprende, un cuerpo principal donde al menos una parte esta hecho de un material de aislacion, al menos una porcion no inflamable dispuesta en el material de aislacion formando al menos un 25% en volumen de dicho componente; y un cable. | |
CO6700840A2 (es) | Teobromina en combinación con un expectorante o un mucolítico para su uso en terapia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |